Q4 2025 Zoetis Inc Earnings Call Transcript
Key Points
- Zoetis Inc (ZTS) reported 6% revenue growth and 7% growth in adjusted net income for the full year 2025, meeting expectations.
- The Simparica franchise grew 12% operationally, with significant contributions from both the US and international markets.
- Companion Animal Diagnostics delivered a robust 13% operational revenue growth, showcasing the success of their innovation strategy.
- Livestock segment achieved 8% organic operational revenue growth, with strong international contributions.
- Zoetis Inc (ZTS) has a diverse portfolio and a robust pipeline, with 12 potential blockbusters in development, indicating future growth potential.
- The OA Pain franchise declined 3% operationally for the year, with Librela sales declining 6% operationally.
- The US market faced economic pressure, particularly affecting Gen Z and millennial pet owners, leading to a decline in therapeutic visits.
- Increased competition and elevated promotional activity in the market have created challenges for Zoetis Inc (ZTS).
- The company experienced a decline in the OA Pain franchise in the US, with a 12% decrease in sales.
- Macroeconomic conditions and competitive pressures are expected to continue impacting growth in 2026.
(Operator Instructions) Welcome to the fourth-quarter and full-year 2025 financial results conference call and webcast for Zoetis. Hosting the call today is Steve Frank, Vice President of Investor Relations for Zoetis.
The presentation materials and additional financial tables are currently posted on the Investor Relations of zoetis.com. The presentation slides can be managed by you, the viewer, and will not be forwarded automatically. In addition, a replay of this call will be available approximately two hours after the conclusion of this call via dial-in or on the Investor Relations section of zoetis.com. (Operator Instructions)
It is now my pleasure to turn the floor over to Steve Frank. Steve, you may begin.
Thank you, operator. Good morning, everyone, and welcome to the Zoetis 2025 full-year and fourth-quarter earnings call. I am joined today by Kristin Peck, our Chief Executive Officer; and Wetteny Joseph, our Chief Financial Officer.
Before we begin, I'll remind
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
